Clinical Trials Logo

Clinical Trial Summary

This is a randomized, double-blind, placebo-controlled, ascending dose, multi-cohort study. The primary objective of this study is to assess the safety and tolerability of single and 7-day repeat oral doses NIM-1324 in healthy adult volunteers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05019950
Study type Interventional
Source NImmune Biopharma
Contact
Status Completed
Phase Phase 1
Start date October 28, 2021
Completion date April 28, 2022

See also
  Status Clinical Trial Phase
Completed NCT01366339 - Tolerance and Pharmacokinetics Study of MNTX Tablets Phase 1
Completed NCT01862835 - Impact of Estradiol Addback Phase 1
Completed NCT01629446 - Lofexidine Mass Balance in Volunteers Phase 1
Completed NCT02026973 - Impact of Endogenous E2 on SSI and GH Rebound Phase 1
Completed NCT03860571 - Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers Phase 1
Recruiting NCT03234504 - Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display
Completed NCT04188730 - A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution Phase 1
Completed NCT02271282 - Estradiol-Receptor Blockade in Older Men and Women Phase 1
Withdrawn NCT03291158 - Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV Phase 1
Completed NCT02802631 - Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults Phase 1